Innovent Biologics Dividend yield

Innovent Biologics is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Innovent Biologics is a company from China, and his stocks are publicly traded.

Innovent Biologics stock dividend

Innovent Biologics paid a total dividend of 0 million HKD last year, for a market value of 53,879 millions (Market Cap 48,603 millions). Innovent Biologics dividend per share is 0.00 HKD, and his stock market price 35.10 HKD.

According to the chart below where dividend yield is displayed, Innovent Biologics, has a dividend yield of 0%, amount in contrast with the positive dividend offered by both the market average and companies from China, Health Care industry, and Pharmaceuticals and Biotechnology sector. This lack of dividends of Innovent Biologics might harm the evolution of share price if the company is not clearly expanding his business.

In addition, you should compare Innovent Biologics stocks dividend with other Pharmaceuticals and Biotechnology companies or other of the best China dividend stocks list.

Innovent Biologics Dividend Payout

About the ability of Innovent Biologics to maintain his current dividend of HKD 0.00 per share, an amount that accounts for 0.00%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Innovent Biologics payout on ernings is currently 0.00%, which is lower than the market average and companies in his industry and sector.

The following figure shows payout ratios over earnings and cashflow of Innovent Biologics, compared againt world market average, China companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.

Innovent Biologics Dividend History

Below you will find a table with the historical evolution of Innovent Biologics's dividend stock, both in percentage and in HKD, its Payout on Earnings and the number of shares (in case there is an split, number shares altered the dividend per share).

Year	Yield	HKD	Paypout	Shares*
Present	0.00%	0.00	0.00%	1,535
2022	0.00%	0.00	0.00%	1,532
2021	0.00%	0.00	0.00%	1,456
2020	0.00%	0.00	0.00%	1,399
2019	0.00%	0.00	0.00%	1,251

*In millions

Innovent Biologics Stock performance

Finally, last moth Innovent Biologics showed a return of 1.40% compared to a worldwide -2.49% average, and a -2.07% of Health Care firms. Over the last year, the company obtained a 4.90% versus a worldwide performance of a 8.71%. More detailed information can be seen in the following graph for China and Pharmaceuticals and Biotechnology firms.